StarTribune
Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Disappointing study results for ImmunoGen

By: MarketMinute.com Stock News
ImmunoGen Inc. (Nasdaq: IMGN) announced that development partner Roche reported disappointing Phase III MARIANNE study results for three HER2-targeted regimens to treat HER2-positive metastatic breast cancer. Shares of the biotechnology company plummeted $4.74 to close at $6.11.


Related Stocks:
Immunogen Inc
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
Browse Business Sections
Latest Columns
Elsewhere in Business
  1. 11m
    Technical glitch temporarily closed southern Norway airspace, causing delays at Oslo airport
  2. 1h
    Electric cars and digital connectivity dominate at Beijing auto show
  3. 3h
    More than just a bowl of noodles, ramen in Japan is an experience and a tourist attraction
  4. 3h
    Stock market today: Asian benchmarks mostly slide as investors focus on earnings
  5. 4h
    US coalition warship shoots down missile fired by Yemen's Houthi rebels over the Gulf of Aden
  6. 4h
    This 'supereasy ramen' recipe shows how easy it is to make the Japanese noodle dish at home
  7. 5h
    Stock market today: Asian benchmarks mostly slide as investors focus on earnings
  8. 5h
    Biden just signed a bill that could ban TikTok. His campaign plans to stay on the app anyway
  9. 5h
    US growth likely slowed last quarter but still pointed to a solid economy
  10. 5h
    TikTok has promised to sue over the potential US ban. What's the legal outlook?
Most Read
  1. UnitedHealth Group's CEO made $25 million in 2023 • Business
  2. St. Cloud warehouse lays off hundreds of workers as Publishers Clearing House downsizes • Business
  3. Icehouse on Eat Street in Mpls. facing eviction for unpaid rent • Business
  4. Surging auto insurance rates squeeze drivers, fuel inflation • Business
  5. Fairview sees financial upturn despite $189M operating loss last year • Business

Business

Complete coverage of business news in the Twin Cities, Minnesota and elsewhere, including Fortune 500 Minnesota companies: UnitedHealth Group, Target, Best Buy, 3M, CHS, U.S. Bancorp, General Mills, C.H. Robinson, Land O’Lakes, Ecolab, Ameriprise Financial, Xcel Energy, Hormel Foods, Thrivent Financial, Polaris, Securian Financial Group, Fastenal and Patterson Cos.

© 2024 StarTribune. All rights reserved.